Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.
Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.
February 23, 2017Plasma Biomarkers: the Key to Early Alzheimer’s Diagnoses
January 30, 2017Meeting the rigorous demands of biosimilar pharmacokinetics
January 23, 2017Cell-Based Assays Keep Biosimilars on Track